Abbott Laboratories said it will withdraw its diet pill Meridia in the U.S. and Canada, after coming under pressure from health regulators who say the drug increases the risk of heart attack and stroke in patients with a history of heart disease.
Sanofi-Aventis SA, the world's fourth-biggest drugmaker, said it is eliminating 1,700 jobs in its U.S. pharmaceutical business in a restructuring triggered by growing generic competition and other factors.
Fifteen academic medical centers, research institutes, and major pharmaceutical companies are collaborating to enhance the speed and quality of clinical trials by harnessing patient data emerging from the coming widespread adoption of electronic health records.
The development of effective data analysis and storage solutions for high-throughput mass spectrometry.
Nano-size approaches fan out across pharma.
Validating a high-throughput angiogenesis assay using laser scanning cytometry.
New antibody-based therapies and emerging research tools bolster this multi-purpose molecule.
ProteaGel Precast Mini Gels are a great alternative to pouring your own SDS-PAGE gels due to the time savings and high resolution provided by a precast gel.
Accelrys, Inc. announced the release of Accelrys Draw 4.0. Accelrys Draw enables scientists to draw, edit, compare, and explore complex biological sequences along with chemical structures and reactions, improving intellectual property management.
MorphoSys AG announced the acquisition of the private German company Sloning BioTechnology GmbH, a biotechnology company developing new methods of synthetic biology.
Cepheid announced a collaboration with Novartis to commercialize a test for the BCR-ABL gene transcript in peripheral blood specimens from patients diagnosed with Philadelphia chromosome-positive chronic myelogenous leukemia.
VentiRx Pharmaceuticals, Inc. announced results from its randomized, placebo controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.
Cumberland Pharmaceuticals Inc. announced the publication of data affirming the safety and efficacy of Caldolor (ibuprofen) Injection in treating fever in critically ill and non-critically ill adults.
Johnson & Johnson asked a federal judge to dismiss a complaint accusing the health care giant of paying millions in kickbacks so nursing homes would put more patients on its popular schizophrenia medication and other drugs.
Biotech firm Genzyme Corp. said its board of directors has rejected Sanofi-Aventis SA's $69 per share offer and has recommended that Genzyme shareholders do not sell their shares to the French drugmaker.